Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05527197 · ClinicalTrials.gov registry record · NA

Patient Reported Function Following Combined First MTP and First TMT Arthrodesis.

A NA study of Hallux Valgus, sponsored by Midwest Bunion Center.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT05527197: Completed NA study of Hallux Valgus, sponsored by Midwest Bunion Center.

NCT05527197 is a NA study of Hallux Valgus that has completed, run by Midwest Bunion Center. The registered enrollment target is 31 participants, below the 76-participant average among 4 other Hallux Valgus trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05527197, a NA study of Hallux Valgus, has completed, sponsored by Midwest Bunion Center.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The goal of the study is to gather sufficient patient data to assess real world postoperative function after a first metatarsophalangeal (MTP) joint arthrodesis done in conjunction with first tarsometatarsal arthrodesis (TMT) (double fusion). Many studies have demonstrated the success of a first MTP joint arthrodesis in eliminating pain and reducing the intermetatarsal angle. Very little research has been published to assess the outcomes of double arthrodesis. Limited research has specifically assessed patients' everyday function and gait following MTP arthrodesis and no studies are available to assess real world function following double arthrodesis. More data that includes patient reported function during activities of daily living is needed to understand the benefits and draw backs of combined first MTP/TMT joint arthrodesis used to treat and correct first ray deformity.

Primary Outcome

Patient responses in the Double Arthrodesis Sports Activities Related to Operative Foot Questionnaire and Sports Activities Related to Operative Foot Questionnaire

Conditions Studied

Interventions

  • DEVICE Lapiplasty

Study Locations (1)

Iowa

  • Foot and Ankle Center of Iowa - Des Moines

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2022-03-29
Est. Completion 2023-08-30
Phase NA
Midwest Bunion Center

1 total trials

What the finished NCT05527197 record still lists

NCT05527197 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 76-participant average among 4 other Hallux Valgus trials with a reported enrollment target (59% lower).

The record links to 1 condition, with Hallux Valgus appearing as the primary indexed condition, and to 1 intervention - of which Lapiplasty is the first listed.

NCT05527197 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT05527197 about?

NCT05527197 is a clinical study titled "Patient Reported Function Following Combined First MTP and First TMT Arthrodesis.". The goal of the study is to gather sufficient patient data to assess real world postoperative function after a first metatarsophalangeal (MTP) joint arthrodesis done in conjunction with first tarsometatarsal arthrodesis (TMT) (double fusion). Many studies have demonstrated the success of a first MTP...

What is the current status of trial NCT05527197?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-03-29. Estimated completion is 2023-08-30.

What conditions does trial NCT05527197 study?

This clinical trial studies the following conditions: Hallux Valgus.

What interventions are being tested in trial NCT05527197?

The interventions under investigation include: Lapiplasty (DEVICE).

Who is sponsoring clinical trial NCT05527197?

This trial is sponsored by Midwest Bunion Center, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05527197 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hallux Valgus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05527197, the US trial registry maintained by the National Library of Medicine. NCT05527197 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.